MONET1-MOtesanib NSCLC Efficacy and Tolerability Study

Clinical trial NCT00460317 · TERMINATED

Trial details

NCT number: NCT00460317
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2007-07-01
Primary completion: 2011-03-01
Enrollment: 1450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.